Glory Health Industry Limited
HKEX:2329.HK
0.132 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,506.285 | 3,904.672 | 9,898.401 | 5,768.896 | 8,093.176 | 6,612.485 | 6,787.415 | 8,034.581 | 6,514.304 | 5,278.546 | 6,835.358 |
| Cost of Revenue
| 2,556.565 | 3,791.155 | 8,651.166 | 4,788.575 | 5,954.455 | 4,013.283 | 3,618.543 | 4,916.491 | 3,835.485 | 2,873.368 | 3,130.684 |
| Gross Profit
| -50.28 | 113.517 | 1,247.235 | 980.321 | 2,138.721 | 2,599.202 | 3,168.872 | 3,118.09 | 2,678.819 | 2,405.178 | 3,704.674 |
| Gross Profit Ratio
| -0.02 | 0.029 | 0.126 | 0.17 | 0.264 | 0.393 | 0.467 | 0.388 | 0.411 | 0.456 | 0.542 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 346.354 | 364.258 | 403.604 | 467.743 | 556.802 | 501.78 | 354.649 | 323.094 | 358.602 | 272.212 | 241.818 |
| Selling & Marketing Expenses
| 83.516 | 96.31 | 263.92 | 273.474 | 305.948 | 206.799 | 194.915 | 260.817 | 246.156 | 182.446 | 184.545 |
| SG&A
| 429.87 | 528.652 | 751.218 | 741.217 | 863.212 | 714.614 | 555.599 | 589.946 | 604.865 | 454.765 | 426.814 |
| Other Expenses
| 0 | 66.713 | 68.728 | 73.025 | 39.071 | 10.659 | 3.655 | 9.986 | 3.215 | 6.953 | 1.913 |
| Operating Expenses
| 429.87 | 826.538 | 290.596 | 99.247 | 132.652 | 121.761 | 516.979 | 232.573 | 155.536 | 111.282 | 715.226 |
| Operating Income
| -484.569 | -415.135 | 496.017 | 239.104 | 1,275.509 | 1,884.588 | 2,613.273 | 2,528.144 | 2,073.954 | 1,950.413 | 3,277.86 |
| Operating Income Ratio
| -0.193 | -0.106 | 0.05 | 0.041 | 0.158 | 0.285 | 0.385 | 0.315 | 0.318 | 0.369 | 0.48 |
| Total Other Income Expenses Net
| -194.051 | -675.209 | 380.85 | 277.617 | 770.192 | 812.88 | 953.86 | 701.659 | 625.185 | 108.596 | 599.972 |
| Income Before Tax
| -678.62 | -1,090.344 | 876.867 | 516.721 | 2,046.163 | 2,697.468 | 3,567.133 | 3,230.427 | 2,699.598 | 2,059.009 | 3,855.784 |
| Income Before Tax Ratio
| -0.271 | -0.279 | 0.089 | 0.09 | 0.253 | 0.408 | 0.526 | 0.402 | 0.414 | 0.39 | 0.564 |
| Income Tax Expense
| -85.117 | 95.051 | 532.352 | 383.076 | 826.55 | 1,128.237 | 1,527.622 | 1,274.739 | 1,116.109 | 852.72 | 1,085.595 |
| Net Income
| -563.971 | -912.782 | 228.333 | 98.74 | 859.764 | 1,008.784 | 1,749.841 | 1,562.956 | 1,260.55 | 950.654 | 2,233.812 |
| Net Income Ratio
| -0.225 | -0.234 | 0.023 | 0.017 | 0.106 | 0.153 | 0.258 | 0.195 | 0.194 | 0.18 | 0.327 |
| EPS
| -0.13 | -0.21 | 0.051 | 0.022 | 0.19 | 0.23 | 0.39 | 0.35 | 0.29 | 0.23 | 0.6 |
| EPS Diluted
| -0.13 | -0.21 | 0.051 | 0.022 | 0.19 | 0.23 | 0.39 | 0.35 | 0.28 | 0.23 | 0.6 |
| EBITDA
| -145.859 | -325.931 | 581.546 | 1,092.049 | 1,351.492 | 1,956.868 | 2,644.988 | 2,560.036 | 2,100.358 | 1,971.352 | 3,301.592 |
| EBITDA Ratio
| -0.058 | -0.083 | 0.059 | 0.055 | 0.167 | 0.296 | 0.39 | 0.319 | 0.322 | 0.373 | 0.483 |